Form D · Other Health Care

Redcliffe Lifetech Inc

Wilmington, DE · CIK 0001941551

Offering snapshot reported Aug 9, 2022 · SEC filing

Reported sold
$46.9M
Offering amount: $46.9M
Investors reported
15
Form D · investor count
Minimum accepted
$103K
Reported outside-investor minimum
First sale
Jan 10, 2022
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$23.5M$46.9MAug 8, 2022: $46,933,880.00Aug 8, 2022Aug 9, 2022: $46,933,880.00Aug 9, 2022

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 9, 2022Amendment$46,933,880$0vs Aug 8, 202215SEC filing
Aug 8, 2022Initial$46,933,880No comparison15SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$1.54M
Finders' fees
$0
Form D file number
021-455203

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
o3 Capital Global Private LimitedNone

Source: Form D, filed Aug 9, 2022. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Aditya Kandoi Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
1013 Centre Rd Ste 403 B
Wilmington, DE, 19805